|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 14, 2017 ) According to the report Anti venom Market, published by Market Data Forecast, the Global market is projected to reach USD 1.49 billion by 2022, at a CAGR of 6.12% from 2017 to 2022.
Anti-venom Market is an antidote to the poison of any venomous animal. It helps in detoxification of the venomous bite and is prepared from the milking venom of the animals. A venomous bite could be fatal in some cases though the most common symptoms include secretion of excessive saliva, breathing problems and muscle weakness.
Get a comprehensive overview of the Anti venom Market: http://www.marketdataforecast.com/market-reports/global-antivenom-market-1580/
Anti venom Market: Drivers & Restraints
Government has taken up initiatives to promote various anti venom products which is a major factor driving the market growth. Increasing cases of snake bites along with numerous pipeline anti venom products are further expected to fuel the market.
The recent withdrawal of anti venom products, high production costs and insufficient funding to develop these products are hindering the market growth.
Get accurate market forecast and analysis on the Anti venom Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/global-antivenom-market-1580/request-sample
Anti venom Market: Segmentation
By Type
• Vaccines
• Hyperimmune Sera
o Homologous
o Heterologous
By animal
• Snakes
• Scorpions
• Spiders
• Others
By Geography
• North America
o United States
o Canada
• Europe
o U.K
o Spain
o Germany
o Italy
o France
• Asia-Pacific
o China
o India
o Japan
o Australia
o South Korea
• Latin America
o Brazil
o Argentina
o Mexico
o Rest of Latin America
• Middle East & Africa
o Middle-East
o Africa
From simple data collation through secondary and primary research toad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/global-antivenom-market-1580/customize-report
Anti-Venom Market: Overview
The Anti-venom Market is dominated by North America accounting 39% of the total market share followed by Europe in 2017. Asia Pacific is predicted to grow at the fastest pace during the forecast period.
Anti venom Market: Key Players
The Anti venom market is highly competitive with a large number of players. Some of the major Companies are Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India) , Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.).
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
